Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
International Journal of Oral and Maxillofacial Surgery
|
September 4, 2007
Satisfaction with treatment outcome in bilateral cleft lip and palate patients
B C M Oosterkamp, P U Dijkstra, H J Remmelink, et al.
Molecular Diversity
|
February 12, 2004
Studies on high-temperature amination reactions of aromatic chlorides using discrete palladium-N-heterocyclic carbene (NHC) complexes and in situ palladium/imidazolium salt protocols
Andrew J McCarroll, David A Sandham, Lisa R Titcomb, et al.
Molecular Pharmacology
|
February 27, 2016
Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy
David A Sykes, Michelle E Bradley, Darren M Riddy, et al.
The Journal of Allergy and Clinical Immunology
|
March 3, 2019
Fevipiprant, a selective prostaglandin D<sub>2</sub> receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
Clare Hardman, Wentao Chen, Jian Luo, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 20, 2021
The Roles of Type 2 Cytotoxic T Cells in Inflammation, Tissue Remodeling, and Prostaglandin (PG) D<sub>2</sub> Production Are Attenuated by PGD<sub>2</sub> Receptor 2 Antagonism
Wentao Chen, Jian Luo, Yuan Ye, et al.
Communications Biology
|
May 20, 2026
The PGD<sub>2</sub>/DP2 axis promotes pro-inflammatory responses but attenuates an antigen-presenting role of human basophils
Jian Luo, Wentao Chen, Martin J Lett, et al.
Journal of Medicinal Chemistry
|
May 31, 2016
Uncoupling the Structure-Activity Relationships of β2 Adrenergic Receptor Ligands from Membrane Binding
Callum J Dickson, Viktor Hornak, Camilo Velez-Vega, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 30, 2025
Genomic crosstalk between carbachol, a muscarinic receptor agonist, and the long-acting β<sub>2</sub>-adrenoceptor agonist, indacaterol, in human airway epithelial cells
Varuna Jayasinghe, Radhika Joshi, Taruna Joshi, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 31, 2012
An investigation into the structure-activity relationships associated with the systematic modification of the β(2)-adrenoceptor agonist indacaterol
David Beattie, David Beer, Michelle E Bradley, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 14, 2009
7-Azaindole-3-acetic acid derivatives: potent and selective CRTh2 receptor antagonists
David A Sandham, Claire Adcock, Kamlesh Bala, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
International Journal of Oral and Maxillofacial Surgery
|
September 4, 2007
Satisfaction with treatment outcome in bilateral cleft lip and palate patients
B C M Oosterkamp, P U Dijkstra, H J Remmelink, et al.
Molecular Diversity
|
February 12, 2004
Studies on high-temperature amination reactions of aromatic chlorides using discrete palladium-N-heterocyclic carbene (NHC) complexes and in situ palladium/imidazolium salt protocols
Andrew J McCarroll, David A Sandham, Lisa R Titcomb, et al.
Molecular Pharmacology
|
February 27, 2016
Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy
David A Sykes, Michelle E Bradley, Darren M Riddy, et al.
The Journal of Allergy and Clinical Immunology
|
March 3, 2019
Fevipiprant, a selective prostaglandin D<sub>2</sub> receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
Clare Hardman, Wentao Chen, Jian Luo, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 20, 2021
The Roles of Type 2 Cytotoxic T Cells in Inflammation, Tissue Remodeling, and Prostaglandin (PG) D<sub>2</sub> Production Are Attenuated by PGD<sub>2</sub> Receptor 2 Antagonism
Wentao Chen, Jian Luo, Yuan Ye, et al.
Communications Biology
|
May 20, 2026
The PGD<sub>2</sub>/DP2 axis promotes pro-inflammatory responses but attenuates an antigen-presenting role of human basophils
Jian Luo, Wentao Chen, Martin J Lett, et al.
Journal of Medicinal Chemistry
|
May 31, 2016
Uncoupling the Structure-Activity Relationships of β2 Adrenergic Receptor Ligands from Membrane Binding
Callum J Dickson, Viktor Hornak, Camilo Velez-Vega, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 30, 2025
Genomic crosstalk between carbachol, a muscarinic receptor agonist, and the long-acting β<sub>2</sub>-adrenoceptor agonist, indacaterol, in human airway epithelial cells
Varuna Jayasinghe, Radhika Joshi, Taruna Joshi, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 31, 2012
An investigation into the structure-activity relationships associated with the systematic modification of the β(2)-adrenoceptor agonist indacaterol
David Beattie, David Beer, Michelle E Bradley, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 14, 2009
7-Azaindole-3-acetic acid derivatives: potent and selective CRTh2 receptor antagonists
David A Sandham, Claire Adcock, Kamlesh Bala, et al.
Page
of 7